基本信息
浏览量:52
职业迁徙
个人简介
Research Interests
I am interested in:
the study of cellular redox signaling, and drug discovery involving elucidation of mechanism/s of action of novel compounds, specifically the characterization and development of agents that possess potential anticancer, chemopreventive, neuroprotective and anti-inflammatory properties.
The goal is to understand the involvement of redox signaling in malignant transformation and to employ this knowledge for the identification and development of rational therapeutic strategies. For the former, I am interested in characterizing how the thioredoxin system contributes to tumorigenesis. In the lab, a novel interaction between thioredoxin and apoptosis-inducing factor (AIF) was identified. The aim is to elucidate the physiological role of the thioredoxin-AIF interaction, which will allow the design and development of potential chemotherapeutic strategies that bring about modulation of the protein-protein interaction to effect cancer cell death. For the latter, my interest is to evaluate the reactivity of electrophilic naturally-occurring compounds and their synthetic derivatives on thiol redox systems and/or redox-sensitive signaling pathways. Electrophilic agents exhibit propensities for nucleophilic molecules such as the thiol-containing amino acid cysteine. Redox-sensitive pathways such as the thioredoxin system, Nrf2-Keap1-ARE and NF-kappaB signaling pathways comprise proteins that contain key cysteines for their biological activities. Modification of these cysteines by the compounds may lead to apoptotic or cytoprotective outcomes.
My laboratory has examined libraries of biologically relevant electrophilic compounds for their potential anti-tumor, cytoprotective, neuroprotective and anti-inflammatory properties. We have identified several classes of electrophilic compounds that are multifunctional through targeting the key nucleophilic amino acids in the molecular targets.
I am interested in:
the study of cellular redox signaling, and drug discovery involving elucidation of mechanism/s of action of novel compounds, specifically the characterization and development of agents that possess potential anticancer, chemopreventive, neuroprotective and anti-inflammatory properties.
The goal is to understand the involvement of redox signaling in malignant transformation and to employ this knowledge for the identification and development of rational therapeutic strategies. For the former, I am interested in characterizing how the thioredoxin system contributes to tumorigenesis. In the lab, a novel interaction between thioredoxin and apoptosis-inducing factor (AIF) was identified. The aim is to elucidate the physiological role of the thioredoxin-AIF interaction, which will allow the design and development of potential chemotherapeutic strategies that bring about modulation of the protein-protein interaction to effect cancer cell death. For the latter, my interest is to evaluate the reactivity of electrophilic naturally-occurring compounds and their synthetic derivatives on thiol redox systems and/or redox-sensitive signaling pathways. Electrophilic agents exhibit propensities for nucleophilic molecules such as the thiol-containing amino acid cysteine. Redox-sensitive pathways such as the thioredoxin system, Nrf2-Keap1-ARE and NF-kappaB signaling pathways comprise proteins that contain key cysteines for their biological activities. Modification of these cysteines by the compounds may lead to apoptotic or cytoprotective outcomes.
My laboratory has examined libraries of biologically relevant electrophilic compounds for their potential anti-tumor, cytoprotective, neuroprotective and anti-inflammatory properties. We have identified several classes of electrophilic compounds that are multifunctional through targeting the key nucleophilic amino acids in the molecular targets.
研究兴趣
论文共 51 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Studies in health technology and informatics (2024): 239-243
International journal of digital healthno. 2 (2023): 2-12
引用0浏览0引用
0
0
Adison Dai Yong Goh,Charmaine Sum May Ng, Yhim Ghee Toh,Joy Boon Ka Chong,Eng-Hui Chew,Kevin Yi-Lwern Yap
Clinical and experimental rheumatologyno. 9 (2021): 1762-1768
JCR: Journal of Clinical Rheumatologyno. 2 (2019): 59-64
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn